These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2861208)

  • 1. The role of adrenergic and dopamine receptors.
    Goldberg LI; Rajfer SI
    Hosp Pract (Off Ed); 1985 Jun; 20(6):67-80. PubMed ID: 2861208
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
    Carey RA; Jacob L
    J Clin Pharmacol; 1989 Mar; 29(3):207-11. PubMed ID: 2566626
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ibopamine--pharmacologic principles].
    Borchard U
    Z Kardiol; 1991; 80 Suppl 8():63-6. PubMed ID: 1686693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
    van Zwieten PA
    Ned Tijdschr Geneeskd; 1990 Nov; 134(47):2281-4. PubMed ID: 1979426
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathomimetic amines: potential clinical applications in ischemic heart disease.
    Goldberg LI; Rajfer SI
    Am Heart J; 1982 Apr; 103(4 Pt 2):724-9. PubMed ID: 6278912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
    Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L
    Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706
    [No Abstract]   [Full Text] [Related]  

  • 9. Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
    Omerovic E; Waagstein F; Swedberg K
    Eur J Heart Fail; 2010 Apr; 12(4):313-4. PubMed ID: 20335348
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?
    Wikström BG
    Eur J Heart Fail; 2010 Aug; 12(8):893. PubMed ID: 20675671
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical efficacy of oral dopaminergic agents: new findings].
    Dei Cas L; Metra M; Nodari S; Raccagni D
    Cardiologia; 1995 Dec; 40(12 Suppl 1):131-8. PubMed ID: 8998705
    [No Abstract]   [Full Text] [Related]  

  • 12. How to treat acute decompensated heart failure in the 'beta-blocker era'?
    Marcondes-Braga FG; Mangini S; Ayub-Ferreira SM; Bocchi EA; Bacal F
    Eur J Heart Fail; 2010 Aug; 12(8):893-4. PubMed ID: 20675672
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic responses induced by dopamine and dobutamine in anesthetized patients premedicated with clonidine.
    Ohata H; Iida H; Watanabe Y; Dohi S
    Anesth Analg; 1999 Oct; 89(4):843-8. PubMed ID: 10512253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenergic beta agonists (adrenaline, dopamine, dobutamine, salbutamol); beta-blockers. Fundamentals and rules of use].
    Lechat P
    Rev Prat; 1998 May; 48(10):1115-21. PubMed ID: 9781158
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

  • 17. Ibopamine--how should it be used?
    Bussmann WD; Wienhöfer K; Frik R
    Cardiology; 1988; 75 Suppl 1():126-37. PubMed ID: 3069210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R; De Marino V; Marino A
    Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A; Reinhart K
    Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
    Nakano T; Isaka N; Konishi T; Tekezawa H; Morimoto Y; Kakuta Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1987 May; 35(5):553-9. PubMed ID: 3112884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.